Skip to main content
Clinical Trials/ISRCTN36285333
ISRCTN36285333
Completed
Not Applicable

To assess the safety and feasibility of administering Dexamphetamine after stroke and its effect on cerebral and cardiac haemodynamics

niversity of Nottingham (UK)0 sites42 target enrollmentOctober 28, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Nottingham (UK)
Enrollment
42
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 28, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Nottingham (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinical stroke 3\-30 days post ictus
  • 2\. Ischaemic stroke on computed tomography (CT)/magnetic resonance imaging (MRI)
  • 3\. Motor weakness (Motricity Index arm 0\-99 inclusive)
  • 4\. Patients expected to stay in hospital for a further 8 days

Exclusion Criteria

  • 1\. Pre\-morbid Barthel Index \<12/20
  • 2\. Dementia
  • 3\. No enteral access in prescence of dysphagia
  • 4\. Moderate\-severe hypertension (systolic blood pressure \[BP] \>160 or diastolic BP \>100\)
  • 5\. Clinical ischaemic heart disease, previous or current angina, myocardial infarction
  • 6\. Hyperexcitability or agitated states
  • 7\. Current hyperthyroidism
  • 8\. History of alcohol or drug abuse
  • 9\. Glaucoma
  • 10\. Predisposition to tics or Tourette Syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials